Investment - Articles - Five reasons to be upbeat about AIM


It’s not hard to find reasons to be negative about the UK’s Alternative Investment Market (AIM). Companies seem to be leaving on a daily basis, former market giants are struggling and IPOs are scarcer than tax breaks on budget day. But birthdays deserve a bit of celebration, so here are five reasons to be positive about the future of AIM according to Nicholas Hyett, Investment Manager at Wealth Club.

 1. The number of companies quoted on AIM could double in the next four years . . .
 The last time the number of companies listed on AIM was this low was back in 2001. That might not sound positive, but the number of companies quoted on AIM more than doubled over the next four years, reaching 1,399 by 2005. Small company Initial Public Offerings (IPOs) are all about market sentiment, and market sentiment can turn very quickly. The relative ease of listing on AIM means smaller and medium sized companies tend to view it favourably during the boom times.

 2. End of US exceptionalism . . .
 One of the reasons AIM, and the UK more generally, has struggled is that valuations for UK listed companies are so much lower than in the US. Companies can shift their main listing to the US and get an instant valuation boost. Alternatively, US companies and private equity buyers can come over to the UK and snap up UK companies on the cheap. That could be changing, recent months have seen the value of US companies fall slightly versus the rest of the world – suddenly the UK isn’t a bargain basement anymore. Companies staying around longer means more opportunity for UK investors to benefit from their growth.

 3. IHT benefits . . . for now!
 AIM’s IHT benefits have been a major source of discussion, and yes they’ve been halved in the last 12 months. Nonetheless, as things stand, AIM shares remain the only way to reduce the inheritance tax due on your ISA – often someone’s largest asset outside their home and pensions and potentially a source of a lot of death duties.

 4. Valuations suggest returns of 41.4% in the next five years
 AIM’s recent struggles mean the AIM All Share currently trades on a Price/Sales ratio of 1.09x, 23.3% below the average since 2012 (the earliest data is available for). Historically a P/S ratio at this level has been associated with returns of 41.4% over the next five years.

 5. AIM today, gone tomorrow
 It’s easy to look at AIM as a failed experiment. The reality is very different. AIM has nurtured a whole host of British success stories for example FeverTree and Abcam, yes some have subsequently been acquired by international buyers or shifted their listing overseas – but there are many that have simply grown up and joined the Main Market. Domino’s Pizza Group, Unite Students and Entain are all companies that started their life as listed companies on AIM.

 For most businesses AIM is the start of a journey rather than the end, departures are not only to be expected but positively welcomed. It’s a sign that the growth market is doing its job. If AIM listed Rosebank Industries’ £1.1 billion fundraise earlier this month is anything to go by, the evidence is that AIM’s not broken yet.
   

Back to Index


Similar News to this Story

Tariff turmoil makes DC providers reassess US allocations
DC providers are underweighting US equities amid concerns over tariffs, dollar weakness and concentration in mega-cap growth stocks. Market turbulence
Comment on on FCA Targeted Support proposals
Responding to the FCA’s proposals on Supporting consumers’ pensions and investment decisions: proposals for targeted support the Association of Profes
Broadstone advises on buyin for BDO LLP with Just Group
Collaborative approach between the Sponsor, advisers and both trustee boards secures transaction at an affordable cost. Benefits for all 1,000+ member

Site Search

Exact   Any  

Latest Actuarial Jobs

Actuarial Login

Email
Password
 Jobseeker    Client
Reminder Logon

APA Sponsors

Actuarial Jobs & News Feeds

Jobs RSS News RSS

WikiActuary

Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.